Circulating tumor cells in breast cancer: applications in personalized medicine. Read more about Circulating tumor cells in breast cancer: applications in personalized medicine.
Equivalent survival after nipple-sparing compared to non-nipple-sparing mastectomy: data from California, 1988-2013. Read more about Equivalent survival after nipple-sparing compared to non-nipple-sparing mastectomy: data from California, 1988-2013.
Breast cancer risk prediction using a clinical risk model and polygenic risk score. Read more about Breast cancer risk prediction using a clinical risk model and polygenic risk score.
Retrospective analysis of molecular scores for the prediction of distant recurrence according to baseline risk factors. Read more about Retrospective analysis of molecular scores for the prediction of distant recurrence according to baseline risk factors.
Risk prediction for local versus regional/metastatic tumors after initial ductal carcinoma in situ diagnosis treated by lumpectomy. Read more about Risk prediction for local versus regional/metastatic tumors after initial ductal carcinoma in situ diagnosis treated by lumpectomy.
Equivalence of MammaPrint array types in clinical trials and diagnostics. Read more about Equivalence of MammaPrint array types in clinical trials and diagnostics.
A phase 1b study of the Akt-inhibitor MK-2206 in combination with weekly paclitaxel and trastuzumab in patients with advanced HER2-amplified solid tumor malignancies. Read more about A phase 1b study of the Akt-inhibitor MK-2206 in combination with weekly paclitaxel and trastuzumab in patients with advanced HER2-amplified solid tumor malignancies.
Trends in the use of mastectomy in women with small node-negative breast cancer treated at US academic centers. Read more about Trends in the use of mastectomy in women with small node-negative breast cancer treated at US academic centers.
Effective treatment of HER2-amplified breast cancer by targeting HER3 and β1 integrin. Read more about Effective treatment of HER2-amplified breast cancer by targeting HER3 and β1 integrin.
Detection of cerebrospinal fluid tumor cells and its clinical relevance in leptomeningeal metastasis of breast cancer. Read more about Detection of cerebrospinal fluid tumor cells and its clinical relevance in leptomeningeal metastasis of breast cancer.
